Home NDC 71687-3003 Pamprin Multi-Symptom
Product NDC 71687-3003
11-digit product format 716873003
Labeler code 71687
Product ID 71687-3003_4fe8f1cd-8250-e908-e063-6394a90a1173
Type HUMAN OTC DRUG
Nonproprietary name Acetaminophen, Pamabrom, Pyrilamine maleate
Dosage form TABLET
Route ORAL
Labeler Focus Consumer Healthcare, LLC
Application M013
Marketing category OTC MONOGRAPH DRUG
Marketing start 2016-06-01
Substance PYRILAMINE MALEATE; PAMABROM; ACETAMINOPHEN
Active strength 15; 25; 500 mg/1; mg/1; mg/1
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 21 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 71687-3003-4 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 71687-3003-1 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 71687-3003-4 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 71687-3003-1 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 71687-3003-4 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 71687-3003-1 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 71687-3003-4 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 71687-3003-1 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 71687-3003-4 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 71687-3003-1 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 71687-3003-4 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 71687-3003-1 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 71687-3003-4 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 71687-3003-1 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Pamprin Multi-Symptom
Brand name suffix Maximum Strength
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength PYRILAMINE MALEATE 15 mg/1 PAMABROM 25 mg/1 ACETAMINOPHEN 500 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination R35D29L3ZA Internal UNII lookup UA8U0KJM72 Internal UNII lookup 362O9ITL9D Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1052637 Internal RxNorm lookup 1053852 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71687-3003-1 Pamprin Multi-SymptomMaximum Strength 20 in 1 BOTTLE, PLASTIC TABLET 20 5 71687-3003-1 Pamprin Multi-SymptomMaximum Strength 1 in 1 CARTON TABLET 1 5 71687-3003-4 Pamprin Multi-SymptomMaximum Strength 1 in 1 CARTON TABLET 1 5 71687-3003-4 Pamprin Multi-SymptomMaximum Strength 40 in 1 BOTTLE, PLASTIC TABLET 40 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71687-3003 PAMPRIN MULTI-SYMPTOM MAXIMUM STRENGTH (ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE) TABLET [FOCUS CONSUMER HEALTHCARE, LLC] 4 Current NDC, Legacy NDC, 4 package rows 20250416_60b3286d-5698-df50-e053-2991aa0afbe2.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 28 of 83 · 1,657 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Acetaminophen ACETAMINOPHEN PUBLIX SUPERMARKETS, INC 08f57305-0c4b-96b1-e063-6394a90a77df 2025-12-19 Warnings Exact identifier application number: M013 Acetaminophen and Diphenhydramine HCL ACETAMINOPHEN AND DIPHENHYDRAMINE HCL PUBLIX SUPERMARKETS, INC 08f549cf-042a-7bf2-e063-6394a90a83ef 2025-12-19 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN WALGREEN CO. b8a855ae-c0a3-0b05-e053-2a95a90ac8a8 2025-12-19 Warnings Exact identifier application number: M013 Childrens Pain and Fever ACETAMINOPHEN Marc Glassman, Inc. f708e1ec-cf2a-4e2b-851f-f6b703f359b2 2025-12-19 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN WALGREEN CO. b375de90-25c7-aa55-e053-2995a90a3cf8 2025-12-19 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN TARGET CORPORATION e64a3c32-5466-0662-e053-2a95a90ae963 2025-12-19 Warnings Exact identifier application number: M013 Acetaminophen Diphenhydramine HCL ACETAMINOPHEN DIPHENHYDRAMINE HCL WALGREENS CO. d92d97a8-0ee3-1206-e053-2a95a90a72a8 2025-12-19 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN SAM'S WEST INC 0c8e7095-0806-4501-e063-6394a90a89aa 2025-12-19 Warnings Exact identifier application number: M013 Acetaminophen Diphenhydramine HCL ACETAMINOPHEN DIPHENHYDRAMINE HCL WALGREEN CO. b3763182-2428-155a-e053-2995a90ab578 2025-12-19 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN WALGREENS e467b78e-9f23-5563-e053-2a95a90a586e 2025-12-19 Warnings Exact identifier application number: M013 Acetaminophen Diphenhydramine HCL ACETAMINOPHEN DIPHENHYDRAMINE HCL Walgreens fd7c3250-35d4-494a-e053-6394a90a2db5 2025-12-19 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN CVS PHARMACY, INC 1ddb8a2b-3081-3eda-e063-6294a90ab82b 2025-12-19 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN CVS PHARMACY, INC b1307d52-10e6-46e1-e053-2995a90a03b6 2025-12-19 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN CVS PHARMACY, INC c2c6d6a1-b492-506d-e053-2995a90aac23 2025-12-19 Warnings Exact identifier application number: M013 Acetaminophen ACETAMINOPHEN FAMILY DOLLAR f8383108-0970-9f1e-e053-6294a90ad38f 2025-12-19 Warnings Exact identifier application number: M013 ACETAMINOPHEN 500 MG ACETAMINOPHEN NUVICARE LLC 591ee107-e953-4982-b75f-13a0afd7c4ae 2025-12-19 Warnings Exact identifier application number: M013 Nuvicare Headache Relief ACETAMINOPHEN, ASPIRIN, CAFFEINE NUVICARE LLC 3ede0fb6-c089-4253-9878-2b01c39e9c87 2025-12-19 Warnings Exact identifier application number: M013 Aspirin Low Dose ASPIRIN NUVICARE LLC 3a4aa3c7-b726-4303-8803-74196fa5637a 2025-12-19 Warnings Exact identifier application number: M013 ACETAMINOPHEN 500 MG ACETAMINOPHEN NUVICARE LLC 95edf7bd-b6a7-4be5-9ad7-8748e7c2d06e 2025-12-19 Warnings Exact identifier application number: M013 Pain Relief PM ACETAMINOPHEN, DIPHENHYDRAMINE NUVICARE LLC 32a5611b-9bf6-4850-a7ff-fa240da04f45 2025-12-19 Warnings Exact identifier application number: M013
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 71687-3003-1 71687300301 1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-1) / 20 TABLET in 1 BOTTLE, PLASTIC 2016-06-01 0000-00-00 No No Current 71687-3003-4 71687300304 1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-4) / 40 TABLET in 1 BOTTLE, PLASTIC 2016-06-01 0000-00-00 No No Current